Cryomass Technologies Correlations
| CRYM Stock | USD 0.05 0.0009 2.01% |
The current 90-days correlation between Cryomass Technologies and Avicanna is -0.05 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cryomass Technologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cryomass Technologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Cryomass Technologies Correlation With Market
Average diversification
The correlation between Cryomass Technologies and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cryomass Technologies and DJI in the same portfolio, assuming nothing else is changed.
Cryomass |
The ability to find closely correlated positions to Cryomass Technologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cryomass Technologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cryomass Technologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cryomass Technologies to buy it.
Moving together with Cryomass OTC Stock
| 0.69 | HLN | Haleon plc | PairCorr |
| 0.73 | TAK | Takeda Pharmaceutical | PairCorr |
| 0.68 | HLNCF | Haleon plc | PairCorr |
| 0.83 | EC | Ecopetrol SA ADR | PairCorr |
| 0.75 | MCD | McDonalds | PairCorr |
| 0.62 | INTC | Intel | PairCorr |
| 0.94 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.73 | GE | GE Aerospace | PairCorr |
| 0.87 | JNJ | Johnson Johnson Sell-off Trend | PairCorr |
| 0.78 | IBM | International Business | PairCorr |
Moving against Cryomass OTC Stock
| 0.79 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.79 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.73 | PTAIY | Astra International Tbk | PairCorr |
| 0.69 | BKRKY | Bank Rakyat | PairCorr |
| 0.65 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.56 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.53 | MKKGY | Merck KGaA ADR Earnings Call Tomorrow | PairCorr |
| 0.52 | TEVA | Teva Pharma Industries | PairCorr |
| 0.47 | TEVA | Teva Pharmaceutical | PairCorr |
| 0.46 | MKGAF | MERCK Kommanditgesells Earnings Call Tomorrow | PairCorr |
| 0.75 | MSFT | Microsoft | PairCorr |
| 0.53 | AA | Alcoa Corp | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Cryomass OTC Stock performing well and Cryomass Technologies OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cryomass Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BBRRF | 6.59 | 0.13 | 0.01 | 0.15 | 8.12 | 17.65 | 70.00 | |||
| RAMMF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| SPBBF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| CVGRF | 4.51 | 0.13 | 0.00 | (0.97) | 0.00 | 5.71 | 139.02 | |||
| BHHKF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| ETRGF | 11.28 | 0.88 | 0.07 | 1.42 | 12.06 | 30.00 | 90.83 | |||
| AVCNF | 5.79 | 0.51 | 0.06 | (1.76) | 6.58 | 17.65 | 48.93 | |||
| SSIC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| LRSV | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| MKGAF | 2.08 | (0.02) | 0.00 | (0.12) | 0.00 | 5.41 | 13.85 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Cryomass Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Cryomass Technologies Corporate Management
Elected by the shareholders, the Cryomass Technologies' board of directors comprises two types of representatives: Cryomass Technologies inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cryomass. The board's role is to monitor Cryomass Technologies' management team and ensure that shareholders' interests are well served. Cryomass Technologies' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cryomass Technologies' outside directors are responsible for providing unbiased perspectives on the board's policies.
| BA BA | Chief Officer | Profile | |
| Caroline Lenardon | Consultant | Profile | |
| Ryan Smith | Chief Meds | Profile | |
| Christian Noel | CEO Director | Profile | |
| Janice Matthews | Consultant | Profile | |
| Patricia Kovacevic | Corp Counsel | Profile | |
| Stephen Schroeder | Consultant | Profile |